Seroprevalence of Chagas infection in the donor population

PLoS Neglected Tropical Diseases

Volumn 6, Issue 7, 2012, Pages

  Zaniello, Ben A ^a   Kessler, Deborah A ^b   Vine, Katherine M ^b   Grima, Kathleen M ^c   Weisenberg, Scott A ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c AMERICAN RED CROSS   (United States)

^d Summitt Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; CHAGAS DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISPANIC; HUMAN; MALE; QUESTIONNAIRE; RADIOIMMUNOPRECIPITATION; RETROSPECTIVE STUDY; SEROPREVALENCE; TRYPANOSOMA CRUZI; UNITED STATES; CLUSTER ANALYSIS; EPIDEMIOLOGY; ETHNIC GROUP; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; CHAGAS DISEASE; CLUSTER ANALYSIS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TRYPANOSOMA CRUZI; YOUNG ADULT;

EID: 84864614833     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001771     Document Type: Article

References (15)

1. Pan American Health Organization (2006) Estimación cuantitativa de la enfermedad de Chagas en les Américas [Spanish]. WHO Department of Control of Neglected Tropical Diseases. Montevideo, Uruguay. OPS/HDM/CD/425-06.
2. Kirchhoff LV, Gam AA, Gilliam FC, ((1987)) American trypanosomiasis (Chagas' disease) in Central American immigrants. Am J Med 82:: 915--20.
3. Kerndt PR, Waskin HA, Kirchhoff LV, Steurer F, Waterman SH, et al. ((1991)) Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 31:: 814--8.
4. Piron M, Vergés M, Muñoz J, Casamitjana N, Sanz S, et al. ((2008)) Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48:: 1862--8.
5. Leiby DA, Herron RM, Read EJ, Lenes BA, Stumpf RJ, ((2002)) Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42:: 549--55.
6. Verani J, Montgomery S, Schulkin J, Anderson B, Jones J, ((2010)) Survey of obstetrician-gynecologists in the United States about Chagas disease. Am J Trop Med Hyg 83:: 891--5.
7. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, et al. ((2006)) Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 46:: 298.
8. Centers for Disease Control and Prevention ((2007)) Blood donor screening for Chagas disease- United States 2006-2007. MMWR Morb Mortal Wkly Rep 56:: 141--3.
9. New York City Department of City Planning (2004) Appendix Table 5-4: Ten Largest Sources of the Foreign-Born by County New York Metropolitan Region, 2000. Available: http://home2.nyc.gov/html/dcp/. Accessed 2010 Aug 20.
10. Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, et al. ((2011)) Chagas Disease among the Latin American Adult Population Attending in a Primary Care Center in Barcelona, Spain. PLoS Negl Trop Dis 5:: e1135.
11. Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, et al. ((2010)) Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 4:: e592.
12. Sicuri E, Muñoz J, Pinazo MJ, Posada E, Sanchez J, et al. ((2011)) Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Tropica 118:: 110--117.
13. Schmunis GA, ((2007)) Epidemiology of Chagas disease in non endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 (suppl.1):: 75--86.
14. Sedyaningsih-Mamahit EA, Schinaia NB, Lazzari SC, Walker ND, Vercauteren GC, ((2004)) The use of blood donor data for HIV surveillance purposes. AIDS 18:: 1849--1851.
15. WHO (2002) Control of Chagas disease: second report of the WHO expert committee. WHO Technical Report Series 905. Geneva.